Molecular Therapy — Nucleic Acids
Delivering the message: mRNA replacement reaches the liver in Niemann-Pick type C1 disease
By Laura Lentini and Emanuele Vitale.
Abstract
Niemann-Pick type C1 (NPC1) disease is an autosomal recessive lysosomal storage disorder affecting both neuronal and peripheral tissues. Several NPC1 mutations impair cholesterol export from late endosomes and lysosomes, leading to lipid accumulation, impaired autophagy, mitochondrial stress, inflammation, and progressive injury in the liver and central nervous system. Although the conditions can be severe, available therapeutic options remain limited. In this issue of Molecular Therapy Nucleic Acids, Koufer and colleagues reported results from an in vivo evaluation of an mRNA-based NPC1 replacement therapy.
Keywords
- Lysosomal Storage Disorders Research
- Niemann-Pick type C1 disease
- intracellular trafficking
- lysosomal storage disease
- gene therapy
- Open access
Source
Published in Molecular Therapy — Nucleic Acids. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
